Inventor · disambiguated record
Matthias John
Also filed as: JOHN MATTHIAS · JOHN MATTHIAS JOHANNES
24 granted patents·17 pending applications·1,065 citations·filing 2002–2023
97Inventor score
Files withMODERNATX INC12MODERNA THERAPEUTICS INC9ALNYLAM PHARMACEUTICALS INC4CRISPR THERAPEUTICS AG2JOHN MATTHIAS2
Top patents by PatentIndex Score
41 records- 0199US10772975B2Modified Polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2017·Granted Sep 15, 2020·37 cites·11 claims
- 0299US9587003B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNA THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·67 cites·19 claims
- 0399US9572896B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Feb 21, 2017·75 cites·11 claims
- 0499US9572897B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·65 cites·19 claims
- 0599US9504734B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·56 cites·19 claims
- 0699US9254311B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·126 cites·14 claims
- 0799US9221891B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·113 cites·13 claims
- 0898US8999380B2Modified polynucleotides for the production of biologics and proteins associated with human diseasemodeRNA Therapeutics·Filed 2013·Granted Apr 7, 2015·258 cites·16 claims
- 0997US9814760B2Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2015·Granted Nov 14, 2017·15 cites·12 claims
- 1096US9782462B2Modified polynucleotides for the production of proteins associated with human diseaseMODERNA THERAPEUTICS INC·Filed 2016·Granted Oct 10, 2017·7 cites·19 claims
- 1195US9827332B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 28, 2017·7 cites·33 claims
- 1295US7786290B2Double-stranded ribonucleic acid with increased effectiveness in an organismALNYLAM PHARMACEUTICALS INC·Filed 2004·Granted Aug 31, 2010·99 cites·31 claims
- 1394US7348314B2Compositions and methods for inhibiting viral replicationALNYLAM EUROPE AG·Filed 2003·Granted Mar 25, 2008·45 cites·3 claims
- 1493US8809293B2Compositions and methods for inhibiting gene expression of hepatitis B virusCHIN DANIEL·Filed 2012·Granted Aug 19, 2014·45 cites·17 claims
- 1591US9828416B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2015·Granted Nov 28, 2017·3 cites·24 claims
- 1690US7994309B2Compositions and methods for inhibiting expression of a mutant geneALNYLAM PHARMACEUTICALS INC·Filed 2010·Granted Aug 9, 2011·6 cites·32 claims
- 1789USRE48345ECompositions and methods for inhibiting gene expression of hepatitis B virusARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Dec 8, 2020·3 cites·69 claims
- 1886US7745418B2Compositions and methods for inhibiting viral replicationALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Jun 29, 2010·4 cites·28 claims
- 1985US8273868B2Compositions and methods for inhibiting viral replicationJOHN MATTHIAS·Filed 2009·Granted Sep 25, 2012·7 cites·24 claims
- 2085US8273870B2Compositions and methods for inhibiting expression of a mutant geneKREUTZER ROLAND·Filed 2011·Granted Sep 25, 2012·6 cites·33 claims
- 2183US7763590B2Compositions and methods for inhibiting expression of a mutant geneALNYLAM PHARMACEUTICALS INC·Filed 2003·Granted Jul 27, 2010·15 cites·7 claims
- 2282US9050375B2Bi-specific digoxigenin binding antibodiesBRAMLAGE BIRGIT·Filed 2010·Granted Jun 9, 2015·6 cites·17 claims
- 2381US2021115101A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2019·Application pending·0 cites
- 2479US2021299278A1Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2020·Application pending·0 cites
- 2576US11708396B2Signal-sensor polynucleotides for the alteration of cellular phenotypesMODERNATX INC·Filed 2021·Granted Jul 25, 2023·0 cites·33 claims
- 2673US2024175014A1Materials and methods for treatment of alpha-1 antitrypsin deficiencyCRISPR THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 2772US2018086807A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2017·Application pending·0 cites
- 2871US2019240351A1Modified polynucleotides for the production of proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 2969US2018170990A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 3067US2017028085A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2016·Application pending·0 cites
- 3161US2019185529A1Signal-sensor polynucleotides for the alteration of cellular phenotypesMODERNATX INC·Filed 2018·Application pending·0 cites
- 3260US2014200261A1Signal-sensor polynucleotides for the alteration of cellular phenotypesHOGE STEPHEN G·Filed 2013·Application pending·0 cites
- 3357US2013064879A1Compositions and Methods for Inhibiting Viral ReplicationJOHN MATTHIAS·Filed 2012·Application pending·0 cites
- 3456US2005119202A1Medicament to treat a fibrotic diseaseFiled 2002·Application pending·0 cites
- 3556US2022273555A1Modified polynucleotides for the production of membrane proteinsMODERNATX INC·Filed 2020·Application pending·0 cites
- 3655US2004248835A1Use of a double-stranded ribonucleic acid for treating an infection with a positivestrand rna-virusFiled 2002·Application pending·0 cites
- 3754US2012322858A1Compositions and Methods for Inhibiting Expression of a Mutant GeneKREUTZER ROLAND·Filed 2012·Application pending·0 cites
- 3852US11851653B2Materials and methods for treatment of alpha-1 antitrypsin deficiencyCRISPR THERAPEUTICS AG·Filed 2016·Granted Dec 26, 2023·0 cites·5 claims
- 3947US2006178324A1Lipophilic derivatives of double-stranded ribonucleic acidHADWIGER PHILIPP·Filed 2004·Application pending·0 cites
- 4042US2016289674A1Modified polynucleotides for the production of membrane proteinsMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4142US2010280102A1Double-stranded ribonucleic acid with increased effectiveness in an organismALNYLAM PHARMACEUTICALS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias John files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →